Trademark: 78277602
Word
LIPOSTABIL
Status
Dead
Status Code
710
Status Date
Friday, July 22, 2011
Serial Number
78277602
Registration Number
2912914
Registration Date
Tuesday, December 21, 2004
Mark Type
1000
Filing Date
Wednesday, July 23, 2003
Published for Opposition
Tuesday, September 28, 2004
Cancellation Date
Friday, July 22, 2011

Trademark Owner History
A. Nattermann & Cie GmbH - Original Registrant

Classifications
5 pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respirattory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use n the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; and pharmaceuticals for the treatment of weight and fat reduction issues
44 providing a website on global computer networks featuring information on pharmaceutical preparations in the fields of pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respirattory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use n the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; and pharmaceuticals for the treatment of weight and fat reduction issues

Trademark Events
Jul 22, 2011
Cancelled Sec. 8 (6-Yr)
Aug 17, 2005
Teas Change Of Correspondence Received
Dec 21, 2004
Registered-Principal Register
Sep 28, 2004
Published For Opposition
Sep 8, 2004
Notice Of Publication
Jul 19, 2004
Approved For Pub - Principal Register
Jul 13, 2004
Letter Of Suspension E-Mailed
Jun 30, 2004
Amendment From Applicant Entered
Jun 30, 2004
Correspondence Received In Law Office
Jun 30, 2004
Paper Received
Jun 9, 2004
Correspondence Received In Law Office
Jun 9, 2004
Teas Response To Office Action Received
Dec 20, 2003
Non-Final Action E-Mailed
Dec 15, 2003
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24